NIH Clinical Center logo     America's Clinical Research Hospital File folder iconExplore the NIH
Clinical Center
Search the Studies - NIH Clinical Research Studies

Protocol Details

Progression of Spinal Fusion in ankylosing Spondylitis

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

04-AR-0205

Sponsoring Institute

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 18
Max Age: N/A

Referral Letter Required

No

Population Exclusion(s)

Children

Special Instructions

Currently Not Provided

Keywords

Computerized Tomography;
Magnetic Resonance Imaging;
Health Outcomes

Recruitment Keyword(s)

ankylosing Spondylitis;
AS;
Spondyloarthropathy;
Spondyloarthritis

Condition(s)

Spondylitis, ankylosing

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Institute of Arthritis and Musculoskeletal and Skin Diseases

This study will evaluate: 1) whether computed tomography (CT) scanning is better than regular x-rays for measuring changes in the stiffness, or fusion, of the spine in patients with ankylosing spondylitis; and 2) if CT can be used to determine how fast extra bone forms in the spine of these patients. Better ways to measure spinal fusion are needed to be able to evaluate the effectiveness of medicines in slowing or stopping its progression. CT uses x-rays to provide detailed pictures of the inside of the body and are valuable for detecting spinal abnormalities because of the precision with which it can show these structures. For the procedure, the patient lies on a table that moves into a large, donut-shaped scanner that can move around the body to take pictures at different angles, which are viewed on a computer monitor.

Patients 18 years of age and older with ankylosing spondylitis who are not currently taking or planning to receive treatment with anti-TNF alpha medications (etanercept, infliximab, adalimumab) for 1 year may be eligible for this study. Participants have eight clinic visits, scheduled at study entry and at 4, 8, 12, 16, 20, 24, and 48 months, at the NIH Clinical Center for the following procedures:

-Clinical assessment (all visits) - includes medical history and physical examination, measurement of spine flexibility with a tape measure and protractor, symptoms questionnaire

-Blood tests for measures of inflammation, including red blood cell sedimentation rate and C-reactive protein level (all visits)

-Urine pregnancy test in women of child-bearing age (visits 1, 4, 7, 8)

-X-rays of the pelvis, low back, and neck (visits 1, 4, 7)

-X-ray of the low back (visit 8)

-CT scan of the low back (visits 1, 4, 7)

-Magnetic resonance imaging (MRI) of the low back (visits 1, 4) - MRI combines a powerful magnet with an advanced computer system and radio waves to produce accurate, detailed pictures of organs and tissues. The patient lies on a table in a narrow cylinder containing a magnetic field, wearing earplugs to muffle loud noises that occur with electrical switching of the magnetic fields. He or she can speak with a staff member via an intercom system at all times during the procedure. During the scan, a contrast dye (gadolinium) is injected into the bloodstream through a catheter (plastic tube inserted in a vein) to brighten the images.

In addition, participants will complete a symptoms questionnaire by mail every 4 months for 2 years between visits 7 and 8.

--Back to Top--

Eligibility

A. LONGITUDINAL STUDY PROTOCOL:

Fifty-five patients will be studied.

INCLUSION CRITERIA:

1. Age 18 years or older

2. Diagnosis of AS by the modified New York criteria

3. Lumbar spine BASRI score of 0, 1, 2, or 3

We will aim to recruit at least 6 patients in each of the following BASRI lumbar spine categories:

- 0 or 1 (normal or suspicious changes)

- 2 (erosions, sclerosis or squaring with or without syndesmophytes or 2 or fewer vertebrae)

- 3 (syndesmophytes on 3 or more vertebrae with fusion of at most 2 vertebrae)

EXCLUSION CRITERIA:

1. Inability to provide informed consent.

2. BASRI lumbar spine score of 4 (complete fusion; 12)

3. Contraindication to MRI scanning based on the NMR Center MRI Safety Screening Questionnaire or size or weight limitations of the scanner.

4. History of allergic reactions to gadolinium-DPTA contrast used for MRI

5. Anticipated unavailability for follow-up over 2 years

6. Pregnancy

7. Onset of AS at age 16 or younger

8. Spondyloarthropathy other than AS

B. CROSS-SECTIONAL (RELIABILITY) STUDY PROTOCOL

Up to 10 patients will be studied.

INCLUSION CRITERIA:

1. Age 18 years or older

2. Diagnosis of AS by the modified New York criteria (5)

3. Lumbar spine BASRI score of 2, or 3 (i.e. presence of at least one syndesmophyte)(12)

EXCLUSION CRITERIA:

1. Inability to provide informed consent

2. BASRI lumbar spine score of 0, 1, or 4 (complete fusion)< TAB>

3. Pregnancy

4. Onset of AS at age 16 or younger

5. Spondyloarthropathy other than AS


--Back to Top--

Citations:

Russell AS, Computer assisted tomography of the apophyseal changes in patients with ankylosing spondylitis. J Rheumatol.1986 Jun;13(3):581-5.

Simkin PA, Apophyseal arthritis limits lumbar motion in patients with ankylosing spondylitis. Arthritis Rheum. 1988 Jun;31(6):798-802.

Viitanen JV, Correlation between mobility restrictions and radiologic changes in ankylosing spondylitis. Spine. 1995 Feb 15;20(4):492-6.

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

Michael M. Ward, M.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
BG 10-CRC RM 4-1339
10 CENTER DR
BETHESDA MD 20814
(301) 496-7263
wardm1@mail.nih.gov

Eileen D. Lange, R.N.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health
Building 10
Room 6N226
10 Center Drive
Bethesda, Maryland 20892
(301) 435-8434
langeeil@mail.nih.gov

Patient Recruitment and Public Liaison Office
Building 61
10 Cloister Court
Bethesda, Maryland 20892-4754
Toll Free: 1-800-411-1222
TTY: 301-594-9774 (local),1-866-411-1010 (toll free)
Fax: 301-480-9793

prpl@mail.cc.nih.gov

Clinical Trials Number:

NCT00085995

--Back to Top--

QUESTIONS?

Contact the Patient Recruitment and Public Liaison Office for:

  • Details on how to participate in a study
  • Details on how to refer a patient to a study

NIH Clinical Studies Information Request


Contact the Office of Communications for:

  • General information about the NIH Clinical Center

www.cc.nih.gov/contact.shtml


Contact the Department Clinical Research Informatics, (DCRI) for:

  • Technical questions about Adobe Acrobat and the PDF format
  • Technical questions about this web server

webmaster@cc.nih.gov